Opinion: I’m a retired doctor. Volunteering at a community clinic gave me an entirely new medical education
“It was only after retiring from mainstream medicine when I fully comprehended the callous limitations of our health…
Read at source →Source
STAT News
Medicine, biotech, and health policy
Health · 702 articles · page 16 of 20 · fetched about 1 hour ago
Americans bought 12% less soda under new SNAP restrictions, study says
The drop in soda purchases is meaningful, but not enormous, one of the study's authors said.
Read at source →
STAT+: HHS document offers new clues to Kennedy’s vaccine plans
Kennedy asks for feedback on new vaccine recommendation categories, how shots are tested.
Read at source →
AdSponsoredSiguimi
Pure chronological social — no algorithm
See who you follow, newest first. Free to join. Posts that stay visible — not buried by an algo.
Join siguimi.com →
STAT+: Pharmalittle: We’re reading about a big Roche investment in the U.S., estrogen patch shortages, and more
Roche's Genentech will invest $750 million to double the size of its existing production facility in Oregon
Read at source →
STAT+: Are cancer patients getting too much drug?
Moderna's stunning surge and drop, AI in scientific writing, and more biotech news from The Readout
Read at source →
Scientists deploy Merck’s Ebola vaccine in DRC
Prostate cancer therapy, Meta glasses in hospital settings, and more health news from Morning Rounds
Read at source →
Focal therapy for localized prostate cancer has divided physicians. Will new data change minds?
Urologic oncologists who treat prostate cancer are split over the benefits of focal therapy compared to traditional…
Read at source →
Opinion: Lil Nas X’s bipolar diagnosis and the paradox of treatment
We continue to romanticize the symptoms of mental health problems, especially when we talk about achievement.
Read at source →
Opinion: A cure for HIV would be a triumph. But it shouldn’t harm survivors
Long-term survivors deserve to see a cure, not fear the losses it might bring.
Read at source →
STAT+: How a Trump loyalist got the FDA nomination
What you need to know about Heidi Overton, and Erica Schwartz's first speech to CDC staff.
Read at source →
STAT+: FDA approves Ultragenyx gene therapy
Regeneron wins ultra-rare disease drug approval, a validating win for mRNA research, and more biotech news from The…
Read at source →
Contrasting legal decisions on gender-affirming care
Heidi Overton's rise under Trump, inside a 5-year-old brain organoid, and other health news from Morning Rounds
Read at source →STAT+: Pharmalittle: We’re reading about a Regeneron rare disease drug, an Ultragenyx gene therapy, and more
A Regeneron drug for an ultra-rare disease that causes bone to grow where it shouldn't won U.S. regulatory approval,…
Read at source →
STAT+: One of the most consequential years for cancer treatment, ever
Between success with a pancreatic cancer drug and now success with an mRNA neoantigen vaccine, it has been a banner…
Read at source →
STAT+: Capricor Therapeutics’ Duchenne treatment is heading for an FDA rejection
Capricor Therapeutics is trying to stave off FDA rejection of its cell therapy for Duchenne muscular dystrophy.
Read at source →
STAT+: How health systems are embracing chatbots to query and summarize patient records
Several large health systems are rolling out AI chatbots to query patient records, because they can save time and…
Read at source →
Opinion: Capricor’s Duchenne muscular dystrophy drug and the countless tiny decisions that can make or break a study
“Regulatory flexibility can be exercised in rare disease without sacrificing rigor,” writes Mindy Leffler, whose son…
Read at source →
Reduce protein to increase longevity? Nutrition experts say that’s a bad idea
Reducing protein intake could increase human longevity, researchers recently suggested. That's a bad idea, for several…
Read at source →
Can reclassifying muscle dysmorphia unlock better care for boys and men?
Males make up about a third of the population struggling with eating disorders in the United States. While these…
Read at source →
Opinion: The global health aid architecture is collapsing. The faith economy isn’t
“Washington has rediscovered faith as a delivery mechanism. The bigger opportunity is faith as a source of capital,”…
Read at source →
STAT+: How Trump loyalist Heidi Overton became the president’s pick to run the FDA
If she wins confirmation as FDA commissioner, Heidi Overton will face plenty of big challenges.
Read at source →
STAT+: New CDC director tells staff she is prepared to speak ‘truth to power’
Then new CDC director told staff she is “very comfortable and very confident ... [in] speaking truth to power.”
Read at source →
Trust in science: A new STAT initiative
Dear Readers, When we launched STAT more than a decade ago, our mission statement promised that we would deliver…
Read at source →
STAT+: Experts scrutinize Huidagene’s disclosures after patient death
Merck and Moderna's mRNA cancer vaccine, an expected nominee to lead the FDA, and more biotech news from The Readout
Read at source →
STAT+: Regeneron drug for disease that causes dangerous bone growth earns FDA approval
A Regeneron drug that treats an ultra-rare disease that causes bone to form where it's not meant to be has won approval.
Read at source →
STAT+: American Cancer Society cancels alcohol industry fundraiser
The American Cancer Society had an optics problem: its annual Wine and Spirits Industry's Gala. It decided to do…
Read at source →
STAT+: Brain organoids, kept alive more than five years, matured like human brains
Brain organoids kept alive more than five years continued to develop and mature, and showed molecular and genetic…
Read at source →STAT+: Pharmalittle: We’re reading about an FDA commish nominee, mRNA cancer vaccine results, and more
President Trump is expected to nominate Heidi Overton, White House deputy director of domestic policy, to serve as the…
Read at source →
Dissecting Chinese trial strategy in wake of deaths
Cancer "vaccine" successfully slowed melanoma, dissecting Chinese trial strategy in wake of deaths, and more health…
Read at source →
STAT+: What Epic did — and didn’t — say about AI at its annual meeting
At Epic's annual meeting, the prevailing question behind closed doors is “What the heck is going on with Epic?”
Read at source →
STAT+: Moderna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trial
A personalized mRNA cancer vaccine succeeded in a late-stage melanoma study, results that could herald a new, powerful…
Read at source →
Accrediting body considers changes to racism curriculum standards for public health schools
The accrediting group for schools of public health is weighing the removal of language that specifically requires…
Read at source →
STAT+: In wake of boy’s death, gene editing experts dissect Huidagene’s decisions
Experts question technical improvements Huidagene tried when using a Duchenne muscular dystrophy treatment strategy…
Read at source →
Opinion: I’m a pediatrician. AI chatbots are grooming my patients
“At present, the law does not recognize that child abuse is child abuse when it’s perpetrated by an algorithm operated…
Read at source →
She grew up unvaccinated. Now she’s a leading voice for science — and empathy
Immunologist Liz Marnik, who grew up unvaccinated, says shaming people who distrust science will do nothing to improve…
Read at source →
Opinion: AI has created a shadow medical system
Financial incentives – health care makes up nearly one-fifth of the American economy – have driven every major AI…
Read at source →